newsfilter
← Latest News
PR Newswire·

Soligenix Announces Pricing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...